ISSN: 0300-7995

Journal Home

Journal Guideline

Current Medical Research and Opinion Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Medical Research and Opinion is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 121. It has a price of 4000 €. It has an SJR impact factor of 0,712 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,712.

Current Medical Research and Opinion focuses its scope in these topics and keywords: treatment, patients, observational, safety, randomized, delivery, efficacy, clinical, study, results, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,712

SJR Impact factor

121

H Index

193

Total Docs (Last Year)

750

Total Docs (3 years)

7365

Total Refs

1702

Total Cites (3 years)

678

Citable Docs (3 years)

2.25

Cites/Doc (2 years)

38.16

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension

Functional, Cognitive and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease

The impact of migraine on work, family, and leisure among young women -a multinational study

Clinical Implications of Dopamine Research in Schizophrenia

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

Focus on Amisulpride

Focus on anastrozole and breast cancer

Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome

The value of post-marketing medication surveys in Parkinson's disease

The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol

Low-density lipoprotein 4: a novel predictor of coronary artery disease severity

The Choice of Antihypertensive Drugs in Patients with Erectile Dysfunction

SHOW MORE ARTICLES

Deleterious Effects of Increased Body Weight Associated with Intensive Insulin Therapy for Type 1 Diabetes: Increased Blood Pressure and Worsened Lipid Profile Partially Negate Improvements in Life Expectancy

Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort

Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study

Differences in Lipid Profiles of Patients Given Rosiglitazone Followed by Pioglitazone

Low Serum Levels of High-density Lipoprotein Cholesterol and Hypolipidaemic Treatment

Treatment of Overactive Bladder with Once-daily Extended-release Tolterodine or Oxybutynin: The Antimuscarinic Clinical Effectiveness Trial (ACET)

Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis

What Impact Would Pancreatic Beta-cell Preservation Have on Life Expectancy, Quality-adjusted Life Expectancy and Costs of Complications in Patients with Type 2 Diabetes? A Projection Using the CORE Diabetes Model

No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment

Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis

A Comparison of Adverse Renovascular Experiences Among Osteoarthritis Patients Treated with Rofecoxib and Comparator Non-selective Non-steroidal Anti-inflammatory Agents

Patient and Physician Satisfaction with Aceclofenac: Results of the European Observational Cohort Study (Experience with Aceclofenac for Inflammatory Pain in Daily Practice)